The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

A study is set to explore if artificial intelligence (AI) can help doctors make better decisions when it comes to treating prostate cancer. While prostate cancer diagnosis has become safer and more ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

When you’re diagnosed with prostate cancer at an early stage, usually stage I or II, it means the disease hasn't spread outside your prostate gland. That means you have a few good treatment options to ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

Add Yahoo as a preferred source to see more of our stories on Google. A study is set to explore if artificial intelligence (AI) can help doctors make better decisions when it comes to treating ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

More than 64,000 people were diagnosed with the cancer in a year, almost 3,000 more than breast cancer which was the previous ...